Can you get pregnant on tirzepatide, and is it safe if you do?

Why tirzepatide and pregnancy don't mix: what regulators have established

The Mounjaro Summary of Product Characteristics (the prescribing document filed with the MHRA) is clear that tirzepatide should not be used during pregnancy. That position is not precautionary guesswork. Animal reproductive studies found adverse effects on the developing foetus at exposures relevant to clinical doses, including reduced foetal weight and skeletal changes. Human data are sparse: pregnant women were not enrolled in the SURMOUNT trials, and post-marketing experience is still accumulating.

The NHS England guidance on weight-management injections reinforces this position, advising that women who are pregnant, breastfeeding, or actively trying to conceive should not take these medicines. It also flags that significant weight loss itself can affect fertility, ovulation sometimes returns, including in women who had assumed they were unlikely to conceive. That is worth bearing in mind if pregnancy is not something you are planning.

So the direct answer is: you should not be on tirzepatide if you could become pregnant without reliable contraception in place. If you are exploring treatment and have questions about your specific circumstances, our page on whether you can take tirzepatide while pregnant covers the regulatory detail before you go further, and a conversation with a prescriber is the right next step. You can find out more about how Mounjaro works and who it is licensed for before you go further.

The contraceptive pill and tirzepatide: a specific interaction to know about

Tirzepatide slows the rate at which food and liquid move through the stomach. For most people that is part of how the medicine supports appetite control. But it creates a practical question for women taking oral contraceptives: if absorption of the pill is delayed or reduced, does that affect how reliably it works?

NHS guidance takes this seriously. Women using a combined or progestogen-only pill are advised to add a barrier method (condoms, for example) during the first four weeks of tirzepatide treatment and for four weeks after every dose increase. The same instruction applies if you are titrating up the schedule as your prescriber directs. This is not a theoretical risk; it is a specific, named recommendation in the NHS England tirzepatide-in-primary-care wraparound care guidance.

There is no equivalent evidence of reduced pill effectiveness for semaglutide, the mechanism is different enough that the same caution does not currently apply. If you are curious how the two medicines compare in other respects, the treatment overview sets out the key differences. For now, the practical takeaway on contraception is straightforward: if you are on the pill and starting tirzepatide, talk to your GP about adding a second method at the dose-change points in your schedule.

What happens if you get pregnant on tirzepatide, and what's still uncertain

First, the certain part: stop taking tirzepatide as soon as you know you are pregnant and contact your GP or maternity team that day. You do not need to wait until your next prescription review. If you are a patient with a nume prescriber and you need to pause treatment urgently, our support team is available seven days a week and can help you manage the transition.

What is uncertain is the exact risk to the developing baby from early exposure before a pregnancy is known. Human clinical trial data simply do not exist yet. Tirzepatide has a half-life of roughly five days, meaning it clears the body gradually over a few weeks after the last dose, but the clinical significance of that window in early pregnancy is not established. For anyone who has been through this situation, our page written for women who have found themselves unexpectedly pregnant on tirzepatide explains the practical steps and what to tell your maternity team. Your maternity team will want to know the dates of your last dose and your estimated conception date.

There is also the question of what to do about weight management during pregnancy. That is a conversation for your obstetric team, not something to manage independently. Some women have existing metabolic conditions (type 2 diabetes or gestational diabetes risk) where the clinical picture becomes more complex. If you want to read more about those specific circumstances, the page covering tirzepatide when pregnant goes into the clinical detail in more depth.

Planning ahead: stopping tirzepatide before trying to conceive

If you are thinking about trying for a baby in the coming months, the right time to talk to your prescriber is now, not once you have stopped contraception. The guidance is that women should stop tirzepatide before attempting conception, and our page on what being pregnant on tirzepatide means for your treatment plan outlines why timing matters and what a wash-out period involves, though the exact recommended interval should be confirmed by your prescriber given your individual circumstances, some clinicians suggest at least one month from the last dose, others longer.

There is also a longer-term consideration. Achieving a lower body weight before pregnancy (rather than during it) is generally associated with better maternal and foetal outcomes. A structured, clinician-supervised approach to weight management before conception is a well-established pathway; your GP or a specialist can help map that out alongside any existing conditions you are managing.

If you would like to understand more about the specific fertility questions around Mounjaro before making a decision, that page covers those questions in detail. And if you are ready to speak to a prescriber about whether tirzepatide is appropriate for you right now, you can check your eligibility through our free consultation, a GPhC-registered prescriber, not an automated system, reads every submission the same day. It can fit around a busy afternoon; many people complete it before the school run.